抗体アレイ／抗体ビーズの市場機会と課題

Abstract

More than 100 companies are developing or have developed antibody array and/or bead platforms. The competition is fierce, but the progress in the field has been slow. The problem has been a disconnect between the capabilities of the available technologies and the demands of the market place.

This analysis goes right to the demands of the marketplace, identifying and analyzing current and future practices, unmet needs, and opportunities and challenges. It provides key information for companies to optimize their strategies to take advantage of the large opportunities and avoid the major pitfalls.

D&MD's Market Opportunities and Challenges for Antibody Arrays and Beads answers crucial questions such as:

• What antibody arrays and beads are currently in use?
• What are the strengths and weaknesses of these platforms?
• How do arrays compare with beads?
• What is the impact of the content problem?
• What are the preferred formats?

Data for this proprietary market research study was obtained through detailed interviews with users in order to characterize opportunities and challenges, trends, current practices and unmet needs. In addition to the interviews, an online quantitative survey was conducted to provide metrics for opportunities and challenges in this space. All research and analysis was conducted by an expert in the field.

Table of Contents

Chapter 1: Executive Summary

Chapter 2: Introduction to Antibody Arrays and Beads

• Description
• Using Antibody Arrays and Beads
• Antibodies and Alternative Capture Agents
• Detection
• Applications

Chapter 3: Market Research Methodology

• Interview Analysis
  • Strengths and Weaknesses
  • Planar Arrays versus Beads
  • Content
  • New Detection Methods
• Survey Analysis
  • Participants
  • Current Use

Chapter 4: Market Model

• Methodology
• Market Model

Chapter 5: Contact Reports

• Abbott Laboratories
• Altana Pharma
• Amgen
• Antigenetics
• Dynavax Technologies
• Eli Lilly .
• German Cancer Research Center
• Inhibitex
• MedImmune Vaccines
• Specialty Laboratories
• Strategic Diagnostics
• University of Tuebingen
• Van Andel Institute